Notificação de entrada na fase nacional - PCT
#1.3
09/23/2025
RPI 2855
Application data
Number
112025004414Type
Filing
Publication
PCT
GB2023052318 Examination has not been requested yet. Without that request by 09/08/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:09/08/2026(14 days left)
Latest action published by the INPI: 09/23/2025. We update with every new RPI gazette, published weekly.
Applicants
IMPERIAL COLLEGE INNOVATIONS LIMITED
GB
MYRICX PHARMA LIMITED
GB
Inventors
A. B. (pessoa física)
GB
E. T. (pessoa física)
GB
R. S. (pessoa física)
GB
R. C. (pessoa física)
GB
R. B. (pessoa física)
CH
IPC Classification
Priority claims
EP
22194959.7 · 09/09/2022
EP
22194984.5 · 09/09/2022
GB
2305541.1 · 04/14/2023
GB
2305546.0 · 04/14/2023
Abstract
CONJUGADO DE FÁRMACO DE ANTICORPO COMPREENDENDO INIBIDOR DE NMT E SEU USO. A presente invenção refere-se a ADCs que compreendem um inibidor de NMT conjugado a um anticorpo por meio de um ligante e usos relacionados.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
09/23/2025
RPI 2855
#1.1
03/18/2025
RPI 2828
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.